An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease

Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Katharine, Estrella, Jane, Rajagopal, Rohit, Shanmugalingam, Praseetha, Simmons, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538055/
https://www.ncbi.nlm.nih.gov/pubmed/28781829
http://dx.doi.org/10.1002/ccr3.1022
_version_ 1783254294197174272
author Gupta, Katharine
Estrella, Jane
Rajagopal, Rohit
Shanmugalingam, Praseetha
Simmons, David
author_facet Gupta, Katharine
Estrella, Jane
Rajagopal, Rohit
Shanmugalingam, Praseetha
Simmons, David
author_sort Gupta, Katharine
collection PubMed
description Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy.
format Online
Article
Text
id pubmed-5538055
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55380552017-08-04 An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease Gupta, Katharine Estrella, Jane Rajagopal, Rohit Shanmugalingam, Praseetha Simmons, David Clin Case Rep Case Reports Given the immune background, we hypothesize that active Grave's hyperthyroidism is a risk factor for an acute phase reaction associated with the use of bisphosphonates. We recommend that in patients with Graves’ thyrotoxicosis and hypercalcemia, consider the risk of an acute phase reaction if planning to give bisphosphonate therapy. John Wiley and Sons Inc. 2017-06-19 /pmc/articles/PMC5538055/ /pubmed/28781829 http://dx.doi.org/10.1002/ccr3.1022 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Gupta, Katharine
Estrella, Jane
Rajagopal, Rohit
Shanmugalingam, Praseetha
Simmons, David
An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title_full An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title_fullStr An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title_full_unstemmed An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title_short An acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed Graves’ disease
title_sort acute phase reaction with intravenous bisphosphonate use in a patient with recently diagnosed graves’ disease
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538055/
https://www.ncbi.nlm.nih.gov/pubmed/28781829
http://dx.doi.org/10.1002/ccr3.1022
work_keys_str_mv AT guptakatharine anacutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT estrellajane anacutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT rajagopalrohit anacutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT shanmugalingampraseetha anacutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT simmonsdavid anacutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT guptakatharine acutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT estrellajane acutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT rajagopalrohit acutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT shanmugalingampraseetha acutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease
AT simmonsdavid acutephasereactionwithintravenousbisphosphonateuseinapatientwithrecentlydiagnosedgravesdisease

Ejemplares similares